Evaluation of fatty acid synthase expression in oesophageal mucosa of patients with oesophagitis, Barrett's oesophagus and adenocarcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 11, 2009, Pages 1533-1541

  Crispino, Pietro ^a   Alò, Piero Luigi ^c   Rivera, Margherita ^a   Barillà, Domenica ^a   Nardi, Francesco ^a   Mariotti, Mauro ^a   Giancarlo, Zotti ^c   Botti, Claudio ^b   Pica, Roberta ^a   Cassieri, Claudio ^a   Unim, Hans ^a   Paoluzi, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Italian National Institute of Heath   (Italy)

^c Azienda Sanitaria Locale (ASL)   (Italy)

Author keywords

Adenocarcinoma; Barrett's oesophagus; Fatty acid synthase

Indexed keywords

FAS ANTIGEN; FATTY ACID SYNTHASE; KI 67 ANTIGEN; PROTEIN P53;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CANCER PATIENT; CELL FUNCTION; CONTROLLED STUDY; CYTOPLASM; DISEASE MARKER; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGITIS; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADENOCARCINOMA; AGED; ENZYMOLOGY; ESOPHAGUS TUMOR; MIDDLE AGED; PATHOLOGY;

ADENOCARCINOMA; ADULT; AGED; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS; FATTY ACID SYNTHETASE COMPLEX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70349571141     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0600-x     Document Type: Article

References (59)

1. PL Alò P Visca A Marci, et al. 1996 Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients Cancer 77 474 482 10.1002/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3. 0.CO;2-K 8630954 10.1002/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0. CO;2-K (Pubitemid 26047568)
2. LG Baggetto 1992 Deviant energetic metabolism of glycolytic cancer cells Biochimie 74 959 974 10.1016/0300-9084(92)90016-8 1477140 10.1016/0300-9084(92) 90016-8 (Pubitemid 23014726)
3. M Beilstein D Silberg 2002 Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma Gastroenterol Clin North Am 31 461 479 10.1016/S0889-8553(02)00013-4 12134613 10.1016/S0889-8553(02)00013-4 (Pubitemid 34761222)
4. AJ Cameron BJ Ott WS Payne 1985 The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus N Engl J Med 313 857 858 4033716
5. D Chalbos C Joeux F Galtier, et al. 1990 Regulation of fatty acid synthase by progesterone in normal and tumoral human mammary glands Rev Esp Fisiol 46 43 46 2204092
6. D Chatelain JF Flejou 2003 High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins Virchows Arch 442 18 24 12536310
7. DJ Drewitz RE Sampliner HS Garewal 1997 The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years Am J Gastroenterol 92 212 215 9040193
8. C Eng M Kiuru MJ Fernandez LA Aaltonen 2003 A role for mitochondrial enzymes in inherited neoplasia and beyond Nat Rev Cancer 3 193 202 10.1038/nrc1013 12612654 10.1038/nrc1013 (Pubitemid 37328871)
9. JI Epstein M Carmichael AW Partin 1995 OA-159 (fatty acid synthase) as an independent predictor in pathological stage in adenocarcinoma of the prostate Urology 45 81 86 10.1016/S0090-4295(95)96904-7 7817483 10.1016/S0090-4295(95) 96904-7
10. GW Falk TW Rice JR Goldblum, et al. 1999 Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia Gastrointest Endosc 49 170 176 10.1016/S0016-5107(99)70482-7 9925694 10.1016/S0016-5107(99)70482-7 (Pubitemid 29111309)
11. RC Fitzgerald 2006 Molecular basis of Barrett's esophagus and esophageal carcinoma Gut 55 1810 1818 10.1136/gut.2005.089144 17124160 10.1136/gut.2005. 089144 (Pubitemid 44893583)
12. JF Fléjou 2005 Barrett's esophagus: from metaplasia to dysplasia and cancer Gut 54 6 12 10.1136/gut.2004.041525 10.1136/gut.2004.041525 (Pubitemid 40293003)
13. JF Flejou D Chatelain 1999 Contribution of new tools to the characterization of Barrett mucosa Gastroenterol Clin Biol 23 20 29
14. Fox JR, Kuwada SK (2000) Today's approach to esophageal cancer. What is the role of the primary care physician? Postgrad Med 107:109-114. doi: 10.3810/pgm.2000.5.1.1061
15. K Geboes P Van Eyken 2000 The diagnosis of dysplasia and malignancy in Barrett's esophagus Histopathology 37 99 107 10.1046/j.1365-2559.2000.00960.x 10931231 10.1046/j.1365-2559.2000.00960.x (Pubitemid 30608506)
16. JR Goldblum GY Lauwers 2002 Dysplasia arising in Barrett's esophagus: diagnostic pitfalls and natural history Semin Diagn Pathol 19 12 19 11936261
17. RC Haggitt 1992 Adenocarcinoma in Barrett's esophagus: a new epidemic? Hum Pathol 23 475 476 10.1016/0046-8177(92)90121-I 1568742 10.1016/0046-8177(92) 90121-I
18. W Hameeteman GNJ Tytgat HJ Houthoff, et al. 1989 Barrett's esophagus: development of dysplasia and adenocarcinoma Gastroenterology 96 1249 1256 2703113
19. Hamilton SR, Aaltonen LA (2000) WHO pathology and genetics: tumors of digestive system. IARC Press, Lyon
20. MK Hong WB Laskin BE Herman, et al. 1995 Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus Cancer 75 423 429 10.1002/1097-0142(19950115)75:2<423::AID- CNCR2820750202>3.0.CO;2-5 7812911 10.1002/1097-0142(19950115)75:2<423:: AID-CNCR2820750202>3.0.CO;2-5
21. JA Jankowski NA Wright SJ Meltzer, et al. 1999 Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus Am J Pathol 154 965 973 10233832
22. R Kim MR Clarke MF Melhem, et al. 1997 Expression of p53, PCNA, and C-erbB-2 in Barrett's metaplasia and adenocarcinoma Dig Dis Sci 42 2453 2462 10.1023/A:1018891923998 9440619 10.1023/A:1018891923998 (Pubitemid 28103779)
23. R Kim JL Weissfeld JC Reynolds, et al. 1997 Etiology of Barrett's esophagus and esophageal adenocarcinoma Cancer Epidemiol Biomarkers Prev 6 369 377 9149898
24. PF Kuhajda 2000 Fatty acid synthase and human cancer: new perspectives on its role in tumor biology Nutrition 16 202 208 10.1016/S0899-9007(99)00266-X 10705076 10.1016/S0899-9007(99)00266-X (Pubitemid 30114274)
25. FP Kuhajda K Jenner FD Wood, et al. 1994 Fatty acid synthesis: a potential selective target for antineoplastic therapy Proc Natl Acad Sci USA 91 6379 6383 10.1073/pnas.91.14.6379 8022791 10.1073/pnas.91.14.6379 (Pubitemid 24200664)
26. T Kusakabe A Nashimoto K Honna, et al. 2002 Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach Histopathology 40 71 79 10.1046/j.1365-2559.2002. 01289.x 11903600 10.1046/j.1365-2559.2002.01289.x (Pubitemid 34107384)
27. DS Levine RC Haggitt PL Blount, et al. 1993 An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus Gastroenterology 105 40 50 8514061
28. DS Levine RC Haggitt S Irvine 1996 Natural history of high-grade dysplasia in Barrett's esophagus Gastroenterology 110 A550
29. JN Li M Gorospe JC Chrest TS Kumaravel MK Evans WF Han ES Pizer 2001 Pharmacological inhibition of fatty acid synthase activity produces cytostatic and cytotoxic effects modulated by p53 Cancer Res 61 1493 1499 11245456
30. L Lundell J Dent J Bennett, et al. 1999 Endoscopic assessment of esophagitis: clinical and functional correlates and further validation of the Los Angeles Classification Gut 45 172 180 10403727
31. E Montgomery JR Goldblum JK Greenson, et al. 2001 Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study Hum Pathol 32 379 388 10.1053/hupa.2001.23511 11331954 10.1053/hupa.2001.23511 (Pubitemid 32378299)
32. CP Morales RF Souza SJ Spechler 2002 Hallmarks of cancer progression in Barrett's esophagus Lancet 360 1587 1589 10.1016/S0140-6736(02)11569-8 12443613 10.1016/S0140-6736(02)11569-8 (Pubitemid 35356377)
33. T Nemoto S Terashima M Kogure Y Hoshino T Kusakabe T Suzuki M Gotoh 2001 Overexpression of fatty acid synthase in oesophageal squamous cell dysplasia and carcinoma Pathobiology 69 6 297 303 10.1159/000064636 12324706 10.1159/000064636 (Pubitemid 36160134)
34. EA Newsholme M Board 1991 Application of metabolic-control logic to fuel utilization and its significance in tumor cells Adv Enzyme Regul 31 225 246 10.1016/0065-2571(91)90015-E 1877389 10.1016/0065-2571(91)90015-E
35. J Ovaska M Miettinen E Kivilasakso 1989 Adenocarcinoma arising in Barrett's esophagus Dig Dis Sci 34 1336 1339 10.1007/BF01538065 2766899 10.1007/BF01538065
36. JD Paulaskis HS Sul 1989 Hormonal regulation of mouse fatty acid synthase gene trascription in liver J Biol Chem 264 574 577
37. ES Pizer C Jackisch FD Wood GR Pasternack NE Davidson FP Kuhajda 1996 Inibition of fatty acid synthasis induces programmed cell death in human breast cancer cells Cancer Res 56 2745 2747 8665507
38. A Rashid ES Pizer M Moga, et al. 1997 Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia Am J Pathol 150 201 208 9006336
39. RH Riddell H Goldman DF Ransohoff, et al. 1983 Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications Hum Pathol 14 931 968 10.1016/S0046-8177(83)80175-0 6629368 10.1016/S0046-8177(83)80175-0
40. CS Robertson JF Mayberry DA Nicholson, et al. 1988 Value of endoscopic surveillance in the detection of neoplastic change in Barrett's esophagus Br J Surg 72 760 763 10.1002/bjs.1800750813 10.1002/bjs.1800750813 (Pubitemid 18199152)
41. AK Rustgi 1997 Biomarkers for malignancy in the columnar-lined esophagus Gastroenterol Clin North Am 26 599 606 10.1016/S0889-8553(05)70316-2 9309407 10.1016/S0889-8553(05)70316-2 (Pubitemid 27453237)
42. RE Sampliner 1998 Practice guidelines on the diagnosis, surveillance and therapy of Barrett's esophagus Am J Gastroenterol 93 1028 1031 10.1111/j.1572-0241.1998.00362.x 9672324 10.1111/j.1572-0241.1998.00362.x (Pubitemid 29080944)
43. TG Schnell SJ Sontag G Chejfec, et al. 2001 Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia Gastroenterology 120 1607 1619 10.1053/gast.2001.25065 11375943 10.1053/gast.2001.25065
44. V Sebastiani P Visca C Botti, et al. 2004 Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma Gynecol Oncol 92 101 105 10.1016/j.ygyno.2003.10.027 14751145 10.1016/j.ygyno.2003.10.027 (Pubitemid 38147378)
45. P Sharma D Reker G Falk, et al. 2001 Progression of Barrett's esophagus to high-grade dysplasia and cancer-preliminary results of the Barrett's esophagus study trial Gastroenterology 120 A16
46. P Sharma K MCQuaid J Dent, et al. 2004 A critical review of the diagnosis and management of Barrett's esophagus : the AGA Chicago Workshop Gastroenterology 127 310 330 10.1053/j.gastro.2004.04.010 15236196 10.1053/j.gastro.2004.04.010 (Pubitemid 38962298)
47. S Smith 1994 The animal fatty acid synthase: one gene, one polypeptide, seven enzymes FASEB J 8 1248 1259 8001737
48. AM Smith CA Maxwell-Armstrong NT Welch, et al. 1999 Surveillance for Barrett's esophagus in the UK Br J Surg 86 276 280 10.1046/j.1365-2168.1999. 01015.x 10100803 10.1046/j.1365-2168.1999.01015.x (Pubitemid 29090200)
49. SJ Spechler AH Robbins HB Rubins, et al. 1984 Adenocarcinoma and Barrett's esophagus. An overrated risk Gastroenterology 87 927 933 6468881
50. N Vakil SV Zanten P Kahrilas, et al. 2006 The Montreal definition and classification of gastresophageal reflux disease: a global evidence-based consensus Am J Gastroenterol 101 1900 1920 10.1111/j.1572-0241.2006.00630.x 16928254 10.1111/j.1572-0241.2006.00630.x (Pubitemid 44166604)
51. AH Van Der Veen J Dees JD Blankenstein, et al. 1989 Adenocarcinoma in Barrett's esophagus: an overrated risk Gut 30 14 18 10.1136/gut.30.1.14 2920919 10.1136/gut.30.1.14
52. P Visca V Sebastiani C Botti, et al. 2004 Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma Anticancer Res 24 4169 4173 15736468 (Pubitemid 40468723)
53. SJ Wakil 1989 Fatty acid synthase, a proficient multifunctional enzyme Biochemistry 28 4523 4530 10.1021/bi00437a001 2669958 10.1021/bi00437a001 (Pubitemid 19151020)
54. L Weiss GE Hoffmann R Schreiber H Andres E Fuchs E Korber HJ Kolb 1986 Fatty acid biosynthesis in man, a pathway of minor importance Biol Chem Hoppe Seyler 367 905 912 3790257
55. M Werner J Mueleer A Walch, et al. 1999 The molecular pathology of Barrett's esophagus Histol Histopathol 14 553 559 10212817
56. AP Weston AS Badr RS Hassanein 1999 Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma Am J Gastroenterol 94 3413 3419 10.1111/j.1572-0241.1999.01602.x 10606296 10.1111/j.1572-0241.1999. 01602.x
57. AP Weston SK Banerjee P Sharma, et al. 2001 p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression Am J Gastroenterol 96 1355 1362 10.1111/j.1572-0241. 2001.03851.x 11374668 10.1111/j.1572-0241.2001.03851.x
58. BP Wijnhoven HW Tilanus WN Dinjens 2001 Molecular biology of Barrett's adenocarcinoma Ann Surg 233 322 337 10.1097/00000658-200103000-00005 11224619 10.1097/00000658-200103000-00005 (Pubitemid 32187810)
59. M Younes A Ertan LV Lechago, et al. 1997 p53 protein accumulation is a specific marker of malignant potential in Barrett's metaplasia Dig Dis Sci 42 697 701 10.1023/A:1018828207371 9125634 10.1023/A:1018828207371